Prudential PLC Has $16.15 Million Position in Danaher Corporation $DHR

Prudential PLC lifted its stake in shares of Danaher Corporation (NYSE:DHR) by 18.3% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 81,748 shares of the conglomerate’s stock after purchasing an additional 12,632 shares during the quarter. Prudential PLC’s holdings in Danaher were worth $16,148,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Red Tortoise LLC grew its stake in shares of Danaher by 175.0% during the second quarter. Red Tortoise LLC now owns 154 shares of the conglomerate’s stock worth $30,000 after buying an additional 98 shares during the last quarter. Ramirez Asset Management Inc. acquired a new stake in shares of Danaher during the 2nd quarter valued at $40,000. Costello Asset Management INC bought a new stake in Danaher during the 1st quarter worth $41,000. Strengthening Families & Communities LLC increased its holdings in Danaher by 81.4% in the 1st quarter. Strengthening Families & Communities LLC now owns 254 shares of the conglomerate’s stock worth $52,000 after purchasing an additional 114 shares in the last quarter. Finally, Saudi Central Bank bought a new position in Danaher in the first quarter valued at about $52,000. Institutional investors own 79.05% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on DHR shares. TD Cowen upped their price objective on Danaher from $250.00 to $260.00 and gave the company a “buy” rating in a research note on Wednesday, October 22nd. Bank of America decreased their price target on shares of Danaher from $230.00 to $220.00 and set a “buy” rating for the company in a research report on Monday, September 22nd. Rothschild Redb cut shares of Danaher from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, October 8th. Wells Fargo & Company reaffirmed a “positive” rating on shares of Danaher in a research report on Thursday, October 23rd. Finally, Wall Street Zen lowered Danaher from a “buy” rating to a “hold” rating in a research report on Monday, November 10th. Eighteen equities research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $243.39.

Insider Buying and Selling at Danaher

In related news, SVP Brian W. Ellis sold 21,776 shares of the business’s stock in a transaction dated Wednesday, November 12th. The stock was sold at an average price of $219.23, for a total value of $4,773,952.48. Following the completion of the sale, the senior vice president directly owned 14,553 shares of the company’s stock, valued at $3,190,454.19. The trade was a 59.94% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Teri List sold 3,298 shares of the stock in a transaction that occurred on Tuesday, November 18th. The stock was sold at an average price of $226.50, for a total value of $746,997.00. Following the completion of the transaction, the director owned 20,762 shares in the company, valued at approximately $4,702,593. The trade was a 13.71% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders sold 33,026 shares of company stock valued at $7,195,987. Corporate insiders own 11.10% of the company’s stock.

Danaher Stock Performance

DHR stock opened at $222.58 on Thursday. The firm has a market cap of $157.22 billion, a PE ratio of 45.89, a price-to-earnings-growth ratio of 3.28 and a beta of 0.81. The company has a current ratio of 1.52, a quick ratio of 1.10 and a debt-to-equity ratio of 0.33. The stock has a 50-day moving average price of $207.29 and a 200-day moving average price of $201.61. Danaher Corporation has a 1-year low of $171.00 and a 1-year high of $258.23.

Danaher (NYSE:DHR) last released its earnings results on Monday, October 20th. The conglomerate reported $1.89 EPS for the quarter, topping the consensus estimate of $1.72 by $0.17. Danaher had a return on equity of 10.92% and a net margin of 14.44%.The business had revenue of $6.05 billion during the quarter, compared to analysts’ expectations of $6 billion. During the same quarter last year, the firm posted $1.71 earnings per share. The firm’s revenue was up 4.4% on a year-over-year basis. As a group, equities research analysts expect that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, October 31st. Shareholders of record on Friday, September 26th were issued a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date was Friday, September 26th. Danaher’s dividend payout ratio (DPR) is presently 26.39%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.